In 2007, the Centers for Disease Control and Prevention estimates that 1000 cases of invasive meningococcal disease (IMD) occurred in the United States, with 130 (13%) case fatalities and an equal ...

HEALTH experts are alarmed by the invasive meningococcal disease (IMD), with Serogroup B identified as the leading cause, accounting for approximately 68 percent of cases over the years.

Susan Pearce holds her baby Jessica, 13-months-old while she receives the free Meningococcal B injection at Medical HQ in Glynde, Adelaide, Monday, October 1, 2018. (AAP Image/David Mariuz ...

In February 2010, a quadrivalent conjugate vaccine (Menveo; Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis ...

The majority of invasive meningococcal disease cases in high school students are preventable if national recommendations on meningococcal conjugate vaccine are fully implemented. The results of ...

The Meningococcal Vaccine Market has been experiencing significant growth in recent years, driven by increasing awareness about meningococcal disease and the importance of vaccination. According to ...

Researchers make leap in biologically controlling diseases spread by mosquitoes The UK Health Security Agency confirmed 205 cases of invasive meningococcal disease in England in 2021-22 ...

“There is an inconsistent approach towards meningococcal vaccine implementation ... emphasizing the dangers of the disease and the effectiveness of preventative vaccines.

MenABCWY covers five of the six serogroups that cause most disease worldwide, with the B, C, and Y strains responsible for most cases of invasive meningococcal disease (IMD) encountered in the US.

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.